Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.

[1]  D. Packer,et al.  Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation , 2021, Europace.

[2]  G. Lip,et al.  Atrial Fibrillation in the United Kingdom: Predicting Costs of an Emerging Epidemic Recognising and Forecasting the Cost Drivers of Atrial Fibrillation-related costs. , 2020, European heart journal. Quality of care & clinical outcomes.

[3]  K. Kuck,et al.  Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST) , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  C. Morillo,et al.  Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. , 2020, The New England journal of medicine.

[5]  M. Shao,et al.  Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. , 2020, The New England journal of medicine.

[6]  F. Anselme,et al.  Quality of life measured in first-line therapy during the Cryo-FIRST study: a comparison between cryoballoon catheter ablation versus antiarrhythmic drug therapy , 2020 .

[7]  J. Healey,et al.  The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. , 2020, The Canadian journal of cardiology.

[8]  G. Breithardt,et al.  Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.

[9]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[10]  A. Verma,et al.  Quality of Life and Health Care Utilization in the CIRCA-DOSE Study. , 2020, JACC. Clinical electrophysiology.

[11]  U. Schotten,et al.  Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  H. Calkins,et al.  Cryoballoon Ablation of Pulmonary Veins for Persistent Atrial Fibrillation: Results From the Multicenter STOP Persistent AF Trial. , 2020, Heart rhythm.

[13]  George A. Johnson,et al.  Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. , 2020, Journal of the American College of Cardiology.

[14]  J. Andrade,et al.  Efficacy and Safety of Same-Day Discharge for Atrial Fibrillation Ablation. , 2020, JACC. Clinical electrophysiology.

[15]  John Sapp,et al.  Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. , 2019, Circulation.

[16]  H. Crijns,et al.  Long-term outcomes of cryoballoon-based left atrial appendage isolation in addition to pulmonary vein isolation in persistent atrial fibrillation. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  Emily C. O'Brien,et al.  Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score. , 2019, Circulation. Cardiovascular quality and outcomes.

[18]  M. Mansour,et al.  Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study. , 2019, JACC. Clinical electrophysiology.

[19]  Hugh Calkins,et al.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Journal of the American College of Cardiology.

[20]  Yong-Jin Kim,et al.  Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study , 2018, PloS one.

[21]  P. O’Neill,et al.  Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience. , 2018, Heart rhythm.

[22]  P. Vardas,et al.  Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring , 2018, Clinical cardiology.

[23]  D. Mark,et al.  Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design , 2018, American heart journal.

[24]  Paul J. Wang,et al.  Cryoballoon Ablation for Atrial Fibrillation: a Comprehensive Review and Practice Guide , 2018, Korean circulation journal.

[25]  Atul Verma,et al.  Catheter ablation for the treatment of atrial fibrillation is associated with a reduction in health care resource utilization , 2017, Journal of cardiovascular electrophysiology.

[26]  M. Chung,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2017, Heart rhythm.

[27]  P. Lambiase,et al.  Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible? , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  J. Goldberger,et al.  Cryoballoon versus Radiofrequency Catheter Ablation in Atrial Fibrillation: A Meta‐Analysis , 2016, Journal of cardiovascular electrophysiology.

[29]  Prashanthan Sanders,et al.  The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. , 2016, European heart journal.

[30]  S. Pocock,et al.  Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. , 2016, The New England journal of medicine.

[31]  J. Ioannidis,et al.  Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality. , 2016, JACC. Clinical electrophysiology.

[32]  L. Fauchier,et al.  Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  Prashanthan Sanders,et al.  Approaches to catheter ablation for persistent atrial fibrillation. , 2015, The New England journal of medicine.

[34]  F. Biancari,et al.  Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[35]  K. Ellenbogen,et al.  Quantification of the cryoablation zone demarcated by pre- and postprocedural electroanatomic mapping in patients with atrial fibrillation using the 28-mm second-generation cryoballoon. , 2015, Heart rhythm.

[36]  Stanley Nattel,et al.  The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. , 2014, Circulation research.

[37]  J. Healey,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. , 2014, JAMA.

[38]  J. Andrade,et al.  Histopathology of Cryoballoon Ablation‐Induced Phrenic Nerve Injury , 2014, Journal of cardiovascular electrophysiology.

[39]  J. Andrade,et al.  Catheter Cryoablation: Biology and Clinical Uses , 2013, Circulation. Arrhythmia and electrophysiology.

[40]  J. Hartikainen,et al.  Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. , 2012, The New England journal of medicine.

[41]  M. Reynolds,et al.  Health Outcomes With Catheter Ablation or Antiarrhythmic Drug Therapy in Atrial Fibrillation: Results of a Propensity-Matched Analysis , 2012, Circulation. Cardiovascular quality and outcomes.

[42]  G. David,et al.  Healthcare Utilization and Expenditures in Patients with Atrial Fibrillation Treated with Catheter Ablation , 2012, Journal of cardiovascular electrophysiology.

[43]  Lesley H. Curtis,et al.  Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007 , 2012, Circulation. Cardiovascular quality and outcomes.

[44]  Bernard Thibault,et al.  Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. , 2011, Heart rhythm.

[45]  Nick Freemantle,et al.  Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[46]  G. Hindricks,et al.  Complications of Atrial Fibrillation Ablation in a High‐Volume Center in 1,000 Procedures: Still Cause for Concern? , 2009, Journal of cardiovascular electrophysiology.

[47]  Matthew R. Reynolds,et al.  Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses , 2009, Circulation. Arrhythmia and electrophysiology.

[48]  V. Santinelli,et al.  Atrial fibrillation progression and management: a 5-year prospective follow-up study. , 2008, Heart rhythm.

[49]  G. Lamas,et al.  Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective , 2008, Journal of medical economics.

[50]  Matthew Reynolds,et al.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[51]  Gregory Y H Lip,et al.  Quality of life in patients with atrial fibrillation: a systematic review. , 2006, The American journal of medicine.

[52]  J. Ruskin,et al.  Economic burden and co‐morbidities of atrial fibrillation in a privately insured population , 2005, Current medical research and opinion.

[53]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[54]  G. Mensah,et al.  Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention , 2003, Circulation.

[55]  P. Khairy,et al.  Lower Incidence of Thrombus Formation With Cryoenergy Versus Radiofrequency Catheter Ablation , 2003, Circulation.

[56]  J. Camm,et al.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. , 2000, Journal of the American College of Cardiology.

[57]  A. Gage,et al.  Mechanisms of tissue injury in cryosurgery. , 1998, Cryobiology.

[58]  A A Gage,et al.  Minimally invasive cryosurgery--technological advances. , 1997, Cryobiology.

[59]  J. Dayan,et al.  Analysis of the inverse problem of freezing and thawing of a binary solution during cryosurgical processes. , 1995, Journal of biomechanical engineering.

[60]  D A Whalen,et al.  Effect of varying freezing and thawing rates in experimental cryosurgery. , 1985, Cryobiology.

[61]  D. K. Whittaker.  Mechanisms of tissue destruction following cryosurgery. , 1984, Annals of the Royal College of Surgeons of England.

[62]  P. Mazur.  Cryobiology: the freezing of biological systems. , 1970, Science.

[63]  W. Gill,et al.  Repeated Freeze–Thaw Cycles in Cryosurgery , 1968, Nature.

[64]  H. Meryman.  Mechanics of freezing in living cells and tissues. , 1956, Science.